Summary Dividend stocks have been overvalued due to the influx of retirees seeking income, but Pfizer is an exception.
Cory Cramer is a contributor for Seeking Alpha, a platform for investment research and analysis. His articles cover a range of topics related to investing, including portfolio management strategies, stock analysis, and market trends. Cory aims to provide valuable insights and perspectives to help investors make informed decisions.